COM:G1THERAPEUTICS
G1 Therapeutics, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnology Researchwebsite
g1therapeutics.comcrunchbase
g1-therapeuticslinkedin
g1-therapeutics-inc-founding date
Jan 01, 2008ipo date
May 17, 2017
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing regimen or t...Show More